DAVID SHIMA

Person

BOSTON, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Combination therapy for the treatment of ocular neovascular disorders
- Patent number 8,685,397
- Issue date Apr 1, 2014
- Ophthotech Corporation
- David Shima
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy for the treatment of ocular neovascular disorders
- Patent number 8,206,707
- Issue date Jun 26, 2012
- Ophthotech Corporation
- David Shima
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy for the treatment of ocular neovascular disorders
- Patent number 8,187,597
- Issue date May 29, 2012
- Ophthotech Corporation
- David Shima
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy for the treatment of ocular neovascular disorders
- Patent number 7,759,472
- Issue date Jul 20, 2010
- Ophthotech Corporation
- David Shima
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Combination Therapy for the Treatment of Ocular Neovascular Disorders
- Publication number 20110200593
- Publication date Aug 18, 2011
- Ophthotech Corporation
- DAVID SHIMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
- Publication number 20100129364
- Publication date May 27, 2010
- OPHTHOTECH CORPORATION
- DAVID SHIMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
- Publication number 20100119522
- Publication date May 13, 2010
- OPHTHOTECH CORPORATION
- DAVID SHIMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
- Publication number 20100111942
- Publication date May 6, 2010
- OPHTHOTECH CORPORATION
- DAVID SHIMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sequencing of modified nucleic acid molecules
- Publication number 20060019298
- Publication date Jan 26, 2006
- David T. Shima
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Enhanced biologically active conjugates
- Publication number 20050260651
- Publication date Nov 24, 2005
- Pericles Calias
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Facilitation of iontophoresis using charged moieties
- Publication number 20050260153
- Publication date Nov 24, 2005
- Pericles Calias
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy for the treatment of ocular neovascular disorders
- Publication number 20050096257
- Publication date May 5, 2005
- David Shima
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
5'-and 3'-capped aptamers and uses therefor
- Publication number 20050096290
- Publication date May 5, 2005
- Anthony P. Adamis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Drug delivery device and syringe for filling the same
- Publication number 20040230183
- Publication date Nov 18, 2004
- Wisam Breegi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

DAVID SHIMA

Person

Patents Grantslast 30 patents

Combination therapy for the treatment of ocular neovascular disorders

Combination therapy for the treatment of ocular neovascular disorders

Combination therapy for the treatment of ocular neovascular disorders

Combination therapy for the treatment of ocular neovascular disorders

Patents Applicationslast 30 patents

Combination Therapy for the Treatment of Ocular Neovascular Disorders

COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS

COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS

COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS

Sequencing of modified nucleic acid molecules

Enhanced biologically active conjugates

Facilitation of iontophoresis using charged moieties

Combination therapy for the treatment of ocular neovascular disorders

5'-and 3'-capped aptamers and uses therefor

Drug delivery device and syringe for filling the same